Company / Revenue
Celularity Inc Revenue History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$26.6M
FY2025
5-year range
$18.0M / $54.2M
FY2021-FY2025
Trend
-51.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $23M to $27M over the past 2 years.
Based on SEC 10-K filings.
$27M in FY2025 with a 3-year CAGR of +13.9%.
Improved from $23M to $27M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +13.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +13.9%, indicating consistent growth.
- In FY2025, revenue decreased 51.0% year-over-year.
- Peak revenue was recorded in FY2024.
- Lowest revenue in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -9.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $26.6M | -51.0% |
| FY2024 | $54.2M | +138.1% |
| FY2023 | $22.8M | +26.7% |
| FY2022 | $18.0M | -15.7% |
| FY2021 | $21.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026